Evidence map›Paper›PMID 21930711›Full record

ArticleThe Journal of biological chemistry2011

Protein phosphatase 2A (PP2A)-specific ubiquitin ligase MID1 is a sequence-dependent regulator of translation efficiency controlling 3-phosphoinositide-dependent protein kinase-1 (PDPK-1).

Beatriz Aranda-Orgillés, Désirée Rutschow, Raphael Zeller, Antonios I Karagiannidis, Andrea Köhler, Changwei Chen, Timothy Wilson, Sven Krause, Stefan Roepcke, David Lilley and 2 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Two Novel PathogenicMolecular syndromology · 2017
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Beatriz Aranda-OrgillésMax-Planck Institute for Molecular Genetics, Ihnestrasse 73, 14195 Berlin, Germany.
Désirée Rutschow
Raphael Zeller
Antonios I Karagiannidis
Andrea Köhler
Changwei Chen
Timothy Wilson
Sven Krause
Stefan Roepcke
David Lilley
Rainer Schneider
Susann Schweiger
Max Planck Institute for Molecular Genetics · DEUniversity of Dundee · GBNinewells Hospital · GBUniversität Innsbruck · AT

Funding

Austrian Science Fund FWF TRP 233Cancer Research UK 11722
6 · The paper itself

Abstract

We have shown previously that the ubiquitin ligase MID1, mutations of which cause the midline malformation Opitz BBB/G syndrome (OS), serves as scaffold for a microtubule-associated protein complex that regulates protein phosphatase 2A (PP2A) activity in a ubiquitin-dependent manner. Here, we show that the MID1 protein complex associates with mRNAs via a purine-rich sequence motif called MIDAS (MID1 association sequence) and thereby increases stability and translational efficiency of these mRNAs. Strikingly, inclusion of multiple copies of the MIDAS motif into mammalian mRNAs increases production of the encoded proteins up to 20-fold. Mutated MID1, as found in OS patients, loses its influence on MIDAS-containing mRNAs, suggesting that the malformations in OS patients could be caused by failures in the regulation of cytoskeleton-bound protein translation. This is supported by the observation that the majority of mRNAs that carry MIDAS motifs is involved in developmental processes and/or energy homeostasis. Further analysis of one of the proteins encoded by a MIDAS-containing mRNA, namely PDPK-1 (3-phosphoinositide dependent protein kinase-1), which is an important regulator of mammalian target of rapamycin/PP2A signaling, showed that PDPK-1 protein synthesis is significantly reduced in cells from an OS patient compared with an age-matched control and can be rescued by functional MID1. Together, our data uncover a novel messenger ribonucleoprotein complex that regulates microtubule-associated protein translation. They suggest a novel mechanism underlying OS and point at an enormous potential of the MIDAS motif to increase the efficiency of biotechnological protein production in mammalian cells.

Indexed as

Protein Biosynthesis3-Phosphoinositide-Dependent Protein KinasesEsophagusHeLa CellsHumansHypertelorismHypospadiasMicrotubule ProteinsNuclear ProteinsProtein Serine-Threonine KinasesRNA-Binding ProteinsRNA, MessengerTranscription FactorsUbiquitin-Protein Ligases3-Phosphoinositide-Dependent Protein KinasesMicrotubule ProteinsMID1 protein, humanNuclear ProteinsPDPK1 protein, humanProtein Serine-Threonine KinasesRNA-Binding ProteinsRNA, MessengerTranscription FactorsUbiquitin-Protein Ligases

Identifiers

PMID21930711
PMCPMC3220588
OpenAlexW1980521034

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.